SCHEMBL6797648

SCHEMBL6797648

CC(C)(C)OC(=O)N1CCC(O)(c2cccs2)CC1.[Li]c1cccs1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.43
OPRD1 P41143 2/20 0.42
OPRK1 P41145 2/20 0.42
OPRM1 P35372 1/20 0.42
OPRL1 P41146 1/20 0.42
GBA1 P04062 1/20 0.40
SCD5 Q86SK9 1/20 0.39
TSHR P16473 2/20 0.39
ALOX15 P16050 1/20 0.39
ATM Q13315 1/20 0.39
MAPK1 P28482 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
CCR1 P32246 1/20 0.36
TACR1 P25103 1/20 0.36
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL986690 0.93 GPR119 (0.47) GPR119OPRD1OPRK1OPRM1OPRL1
SCHEMBL15804318 0.88 GPR119 (0.44) GPR119OPRD1OPRK1OPRM1OPRL1
SCHEMBL31283650 0.86 GPR119 (0.43) GPR119OPRD1OPRK1OPRM1OPRL1
SCHEMBL7695449 0.80 GPR119 (0.44) GPR119OPRD1OPRK1OPRM1OPRL1
SCHEMBL3255190 0.79 GPR119 (0.43) GPR119OPRD1OPRK1GBA1SCD5
SCHEMBL2334586 0.79 OPRM1 (0.47) GPR119OPRM1OPRL1GBA1SCD5
SCHEMBL8347586 0.79 TSHR (0.48) GPR119OPRD1OPRK1GBA1SCD5
SCHEMBL3786845 0.78 GPR119 (0.43) GPR119GBA1SCD5TSHRALOX15
SCHEMBL8355728 0.78 TSHR (0.45) GPR119OPRD1OPRK1GBA1SCD5
SCHEMBL5467320 0.77 SMN1; SMN2 (0.55) OPRD1OPRK1OPRM1OPRL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2004-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction CATSPER1, CYP19A1, PDE12 GPR119 749/4885OPRD1 422/4885OPRK1 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.